J&J Nizoral AD 1% ketoconazole dandruff shampoo approved for OTC use Oct. 10.
This article was originally published in The Tan Sheet
Executive Summary
J&J OTC NIZORAL AD DANDRUFF SHAMPOO GRANTED FDA APPROVAL for the control of flaking, scaling and itching. The agency cleared Johnson & Johnson's application to switch its ketoconazole 1% shampoo (NDA 20-310) on Oct. 10. The product will be marketed by J&J Consumer Products Group. J&J will continue to sell prescription Nizoral 2% shampoo but with a new indication: treatment of tinea versicolor, a topical fungal infection.
You may also be interested in...
Johnson & Johnson President Brings Extensive McNeil Background To Post
Johnson & Johnson's appointment of James Lenehan, 53, as president signals a strong commitment by the company to its consumer products segments, despite the firm's shift in emphasis toward its pharmaceutical business over the past ten years
Johnson & Johnson President Brings Extensive McNeil Background To Post
Johnson & Johnson's appointment of James Lenehan, 53, as president signals a strong commitment by the company to its consumer products segments, despite the firm's shift in emphasis toward its pharmaceutical business over the past ten years
Johnson & Johnson President Brings Extensive McNeil Background To Post
Johnson & Johnson's appointment of James Lenehan, 53, as president signals a strong commitment by the company to its consumer products segments, despite the firm's shift in emphasis toward its pharmaceutical business over the past ten years
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: